Clinical trial

Androgen Suppression Combined With Elective Nodal and Dose Escalated Radiation…

NCT00175396 · University of British Columbia, Other · Unknown status

Key facts

NCT number NCT00175396
Title Androgen Suppression Combined With Elective Nodal and Dose Escalated Radiation Therapy
Official title A Randomized Phase III Study Comparing Androgen Suppression and Elective Pelvic Nodal Irradiation Followed by High Dose 3-D Conformal Boost Versus Androgen Suppression and Elective Pelvic Nodal Irradiation Followed by 125-Iodine Brachytherapy Implant Boost for Patients With Intermediate and High…
Lead sponsor University of British Columbia, Other
Status Unknown status
Phase Phase 3
Study type Interventional
Conditions Prostate Cancer
Intervention type Procedure
Interventions Androgen suppression, radiotherapy, iodine 125 brachytherapy
Enrollment 400
Start date May 1, 2004
Primary completion Dec 1, 2011
Completion Jun 1, 2014
First posted Sep 15, 2005
Last update posted Mar 17, 2014
Countries Canada

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies